A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke

Mohr, J.P., Thompson, J.L.P., Lazar, R.M., Levin, B., Sacco, R.L., Furie, K.L., Kistler, J.P., Albers, G.W., Pettigrew, L.C., Adams, H.P., Jackson, C.M., Pullicino, P.·2001·New England Journal of Medicine
DOI 10.1056/nejmoa011258

Cited by (999)

Items 201–300 of 999

  1. Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries
    François-Emery Cotté, Hicham Benhaddi, Isabelle Duprat-Lomon, Adam Doble, Nick Marchant, Alexia Letierce, Michael Huguet · 2014 · Clinical Therapeutics
  2. Recurrence of Low Back Pain: Definition-Sensitivity Analysis Using Administrative Data
    Radoslaw Wasiak, Glenn Pransky, Santosh K. Verma, Barbara S. Webster · 2003 · Spine
  3. A Retrospective Cohort Study Comparing Stroke Recurrence Rate in Ischemic Stroke Patients With and Without Acupuncture Treatment
    Chun-Chuan Shih, Chien‐Chang Liao, Mao-Feng Sun, Yi‐Chang Su, Chi-Pang Wen, Donald Edward Morisky, Fung-Chang Sung, Chung Y. Hsu, Jaung‐Geng Lin · 2015 · Medicine
  4. Proposal for a Universal Definition of Cerebral Infarction
    Jeffrey L. Saver · 2008 · Stroke
  5. Thrombi of Different Pathologies: Implications for Diagnosis and Treatment
    Carlos G. Santos‐Gallego, Jeremías Bayón, Juan J. Badimón · 2010 · Current Treatment Options in Cardiovascular Medicine
  6. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke
    Basil D. Thanopoulos, Petros D. Dardas, Evangelos Karanasios, Nikolaos Mezilis · 2006 · Catheterization and Cardiovascular Interventions
  7. Differentiating ischemic stroke subtypes: Risk factors and secondary prevention
    Howard S. Kirshner · 2009 · Journal of the Neurological Sciences
  8. Therapy Implications of Transthoracic Echocardiography in Acute Ischemic Stroke Patients
    Tiago Tribolet de Abreu, Sónia Mateus, José Pinto Correia · 2005 · Stroke
  9. Arterial Ischemic Stroke in Neonates, Infants, and Children: An Overview of Underlying Conditions, Imaging Methods, and Treatment Modalities
    Ulrike Nowak‐Göttl, Gudrun Günther, Karin Kurnik, Ronald Sträter, Fenella Jane Kirkham · 2003 · Seminars in Thrombosis and Hemostasis
  10. Fibrin-Targeted PET Probes for the Detection of Thrombi
    Katie L. Ciesienski, Yan Yang, İlknur Ay, Daniel B. Chonde, Galen S. Loving, Tyson A. Rietz, Ciprian Catana, Peter D. Caravan · 2013 · Molecular Pharmaceutics
  11. Recurrence and survival after first-ever stroke in the area of Bajo Aragon, Spain. A prospective cohort study
    Pedro J. Modrego, Rosana Mainar, Laura Turull · 2004 · Journal of the Neurological Sciences
  12. Prevention
    Didier Leys, Hubert Kwieciński, Julien Bogousslavsky, Philip M. Bath, Michael Brainin, Hans‐Christoph Diener, Markku Kaste, Juhani Sivenius, Michael G. Hennerici, Werner Hacke · 2004 · Cerebrovascular Diseases
  13. Treatment of childhood arterial ischemic stroke
    Timothy J. Bernard, Neil A. Goldenberg, Jennifer Armstrong, Catherine Amlie‐Lefond, Heather J. Fullerton · 2008 · Annals of Neurology
  14. Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis
    Tanya N. Turan, Lucian Maidan, George Cotsonis, Michael Lynn, José G. Romano, Steven R. Levine, Marc I. Chimowitz · 2008 · Stroke
  15. Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
    on behalf of the Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN), Juan Carlos Hernández‐Boluda, Eduardo Arellano‐Rodrigo, Francisco Cervantes, Alberto Álvarez‐Larrán, Montse Gómez, Pere Barba, María Isabel Mata, José-Ramón González-Porras, Francisca Ferrer‐Marín et al. · 2015 · Annals of Hematology
  16. Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk
    Heidi Lehtola, Juhani K.E. Airaksinen, Päivi H. Hartikainen, Juha E.K. Hartikainen, Antti Palomäki, Ilpo O. Nuotio, Antti Ylitalo, Tuomas Kiviniemi, Pirjo E. Mustonen · 2017 · European Journal of Neurology
  17. Outcomes After Stroke: Risk of Recurrent Ischemic Stroke and Other Events
    Mitchell S.V. Elkind · 2009 · The American Journal of Medicine
  18. The brain's heart — Therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease
    MingMing Ning, Eng H. Lo, Pei-Chen Ning, Su- Yu Xu, David McMullin, Zareh N. Demirjian, Ignacio Inglessis, G. WILLIAM DEC, Igor F. Palacios, Ferdinando S. Buonanno · 2013 · Pharmacology & Therapeutics
  19. Antiphospholipid syndrome: An evolving story
    Beverley J. Robertson, Mike Greaves · 2006 · Blood Reviews
  20. Patent Foramen Ovale and Cryptogenic Stroke: To Close or Not to Close? Closure: What Else!
    Stephan Windecker, Bernhard Meier · 2008 · Circulation
  21. Silent Ischemic Lesion Recurrence on Magnetic Resonance Imaging Predicts Subsequent Clinical Vascular Events
    Dong‐Wha Kang, Susan Lattimore, Lawrence L. Latour, Steven J. Warach · 2006 · Archives of Neurology
  22. Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
    A M Lorga Filho, AD Azmus, AM Soeiro, AS Quadros, Álvaro Avezum, AC Marques, André Franci, ALL Manica, André Volschan, AAV de Paola et al. · 2013 · Arquivos Brasileiros de Cardiologia
  23. The genetics of ischaemic stroke
    Mar Matarín, Andrew Singleton, John Hardy, James Frederick Meschia · 2009 · Journal of Internal Medicine
  24. International Society of Hypertension (ISH)
    International Society of Hypertension Writing Group · 2003 · Journal of Hypertension
  25. The Problem of Restrictive Thrombectomy Trial Eligibility Criteria
    Thanh Ngoc Nguyen, Jean Raymond, Raul G. Nogueira, Urs Fischer, James Ernest Siegler · 2022 · Stroke
  26. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines
    Kunal Bhatia, Lindsey Ladd, Kelsey Carr, Mario Di Napoli, Jeffrey L. Saver, Louise D. McCullough, Maryam Hosseini Farahabadi, Diana L. Alsbrook, Archana Hinduja, Jorge Ortiz-Garcia et al. · 2023 · Current Neurology and Neuroscience Reports
  27. The Levels of Inflammatory Markers in the Treatment of Stroke Study (Limits): Inflammatory Biomarkers as Risk Predictors after Lacunar Stroke
    Mitchell S.V. Elkind, Jorge M. Luna, Christopher S. Coffey, Leslie Ain McClure, K. M. Liu, Steven L. Spitalnik, Myunghee Cho Paik, Ana Roldan, Carole L. White, Robert G. Hart et al. · 2010 · International Journal of Stroke
  28. Atherosclerotic Vascular Disease Conference
    Mark A. Creager, Daniel W. Jones, J. Donald Easton, Jonathan L. Halperin, Alan T. Hirsch, Alan H. Matsumoto, Patrick T. O’Gara, Robert D. Safian, Gary L. Schwartz, John A. Spittell · 2004 · Circulation
  29. ANTICOAGULATION WITH WARFARIN IN VITREORETINAL SURGERY
    Arthur D. Fu, H Richard McDonald, David F. Williams, Herbert L. Cantrill, Edwin H. Ryan, Robert N. Johnson, Everett Ai, James Michael Jumper · 2007 · Retina
  30. Race-ethnic differences in patent foramen ovale, atrial septal aneurysm, and right atrial anatomy among ischemic stroke patients.
    C. Rodriguez, S. Homma, R. Sacco, M. Di Tullio, R. Sciacca, J. P. Mohr · 2003 · Stroke
  31. Use of Ordinal Outcomes in Vascular Prevention Trials
    Philip M. Bath, Chamila M. Geeganage, Laura J. Gray, Timothy John Collier, Stuart Pocock · 2008 · Stroke
  32. In Vivo Molecular Imaging of Thrombosis and Thrombolysis Using a Fibrin-Binding Positron Emission Tomographic Probe
    İlknur Ay, Francesco Blasi, Tyson A. Rietz, Nicholas Joseph Rotile, Sreekanth Kura, A.-L. Brownell, Helen Day, Bruno L. Oliveira, Richard J. Looby, Peter D. Caravan · 2014 · Circulation Cardiovascular Imaging
  33. Transcatheter Closure of Intracardiac Defects in Adults
    Michael Sukhyun Kim, Andrew J. P. Klein, John D. Carroll · 2007 · Journal of Interventional Cardiology
  34. Patent foramen ovale and stroke
    Shunichi Homma, Marco R. Di Tullio · 2010 · Journal of Cardiology
  35. Management of cryptogenic stroke.
    Josef Finsterer · 2010 · PubMed
  36. Angioplasty and stenting of intracranial stenosis
    Marius Hartmann, Olav Jansen · 2005 · Current Opinion in Neurology
  37. Effect of Aspirin and Warfarin Therapy in Stroke Patients With Valvular Strands
    Shunichi Homma, Marco R. Di Tullio, Robert R. Sciacca, Ralph L. Sacco, J.P. Mohr · 2004 · Stroke
  38. Patent foramen ovale: Unanswered questions
    Mohammad K. Mojadidi, Panagiota Christia, Jason N. Salamon, Jared Liebelt, Tarique Zaman, Rubine Gevorgyan, Nariman Nezami, Sanaullah Mojaddedi, Islam Y. Elgendy, Jonathan M. Tobis et al. · 2015 · European Journal of Internal Medicine
  39. Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy
    Lori‐Ann Linkins, Martin James O'Donnell, J.A. Julian, Clive Kearon · 2010 · Journal of Thrombosis and Haemostasis
  40. Foramen oval permeable: situación actual
    Ignacio Cruz‐González, Jorge Solı́s, Ignacio Inglessis‐Azuaje, Igor F. Palacios · 2008 · Revista Española de Cardiología
  41. Updates on Prevention of Hemorrhagic and Lacunar Strokes
    Hsin-hsi C Tsai, Jong Sung Kim, Éric Jouvent, M. Edip Gurol · 2018 · Journal of Stroke
  42. Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
    Graeme J. Hankey · 2002 · Stroke
  43. Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?
    Muhammad Usman, Lawrence A. Notaro, Rangadham Nagarakanti, Eric Brahin, Scott K. Dessain, Edward J. Gracely, Michael D. Ezekowitz · 2009 · The American Journal of Cardiology
  44. The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment
    John R. Teerlink, Vicente J. Iragui, J.P. Mohr, Peter E. Carson, Paul J. Hauptman, David H. Lovett, Alan Bruce Miller, Ileana L. Piña, Scott Culver Thomson, Paul D. Varosy et al. · 2012 · Drug Safety
  45. Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis
    Thomas L. Ortel, Sreelatha Meleth, Diane Catellier, Mark Andrew Crowther, Doruk Erkan, Paul R. Fortin, David A. Garcia, Nana Haywood, Andrzej Stanislaw Kosinski, Steven R. Levine et al. · 2020 · Journal of Thrombosis and Haemostasis
  46. Cardioembolic Stroke: An Update
    Roger E. Kelley, Alireza Minagar · 2003 · Southern Medical Journal
  47. Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke
    Martin James O'Donnell, Graeme J. Hankey, John W. Eikelboom · 2008 · Stroke
  48. Delivery of Anti-Platelet-Endothelial Cell Adhesion Molecule Single-Chain Variable Fragment-Urokinase Fusion Protein to the Cerebral Vasculature Lyses Arterial Clots and Attenuates Postischemic Brain Edema
    Kristine Edgar Danielyan, Bi‐Sen Ding, Claudia Gottstein, Douglas B. Cines, Vladimir R. Muzykantov · 2007 · Journal of Pharmacology and Experimental Therapeutics
  49. Methodological Challenges in Studying Recurrence of Low Back Pain
    Radoslaw Wasiak, Glenn Pransky, Barbara S. Webster · 2003 · Journal of Occupational Rehabilitation
  50. Secondary Prevention of Atherothrombotic Events After Ischemic Stroke
    Harold P. Adams · 2009 · Mayo Clinic Proceedings
  51. Patent foramen ovale: A new disease?
    Abdenasser Drighil, Hanane El Mosalami, Nadia El Badaoui, Saïd Chraibi, Ahmed Bennis · 2007 · International Journal of Cardiology
  52. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis
    Bernhard Meier, Benedikt Frank, Andreas Wahl, HC Diener · 2012 · European Heart Journal
  53. Intracranial Atherosclerosis: Incidence, Diagnosis and Treatment
    Jong Sung Kim, Dong‐Wha Kang, Sun Uck Kwon · 2005 · Journal of Clinical Neurology
  54. Advances in the management of cardioembolic stroke associated with patent foramen ovale
    Brian Mac Grory, E. Magnus Ohman, Wuwei Feng, Ying Xian, Shadi R. Yaghi, Hooman Kamel, Michael E. Reznik · 2022 · BMJ
  55. Use of Stents to Treat Extracranial Cerebrovascular Disease
    Philip M. Meyers, H. Christian Schumacher, Randall T. Higashida, Megan C. Leary, Louis R. Caplan · 2005 · Annual Review of Medicine
  56. Patent Foramen Ovale and Recurrent Stroke
    Jonathan L. Halperin, Valentı́n Fuster · 2002 · Circulation
  57. The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias
    Tharmanathan, Puvan, Calvert, Melanie, Hampton, John, Freemantle, Nick · 2008 · BMC Medical Research Methodology
  58. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
    Vivek Yerrapu Reddy, Ronald L. Akehurst, Stacey L. Amorosi, Meghan B. Gavaghan, Deanna S. Hertz, David R. Holmes · 2018 · Stroke
  59. Treatment Approaches to Lacunar Stroke
    Alvin S. Das, Robert William Regenhardt, Steven K. Feske, M. Edip Gurol · 2019 · Journal of Stroke and Cerebrovascular Diseases
  60. Cost-Effectiveness of Echocardiography to Identify Intracardiac Thrombus among Patients with First Stroke or Transient Ischemic Attack
    Richard T. Meenan, Somnath Saha, Roger Chou, Karleen Swarztrauber, Kathryn Pyle Krages, Maureen Cecelia O'Keeffe-Rosetti, Marian S. McDonagh, Benjamin K S Chan, Mark C. Hornbrook, Mark Helfand · 2007 · Medical Decision Making
  61. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
    M.P.J. van Goor, C. L. Alblas, Frank W.G. Leebeek, Peter J. Koudstaal, Diederik W.J. Dippel · 2004 · Acta Neurologica Scandinavica
  62. Regional Differences in Incidence and Management of Stroke – Is There Any Difference between Western and Japanese Guidelines on Antiplatelet Therapy?
    Yukito Shinohara · 2006 · Cerebrovascular Diseases
  63. Information Retrieval System for Medical Narrative Reports
    Lior Rokach, Oded Maimon, Mordechai Averbuch · 2004 · Lecture notes in computer science
  64. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack
    Peter AG Sandercock, Orell Mielke, Ming Liu, Carl E Counsell · 2003 · Cochrane Database of Systematic Reviews
  65. Vertebral Artery Origin Stenosis and its Treatment
    Afshin Borhani‐Haghighi, Randall C. Edgell, Salvador Cruz‐Flores, Osama O. Zaidat · 2011 · Journal of Stroke and Cerebrovascular Diseases
  66. Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention
    Kristy Yuan, Scott Eric Kasner · 2018 · Stroke and Vascular Neurology
  67. Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States
    Debora Kamin Mukaz, Neil A. Zakai, Salvador Cruz‐Flores, Louise D. McCullough, Mary Cushman · 2020 · Stroke
  68. Vitamin K Antagonists and Risk of Subdural Hematoma
    Ben J. Connolly, Lesly A. Pearce, Robert G. Hart · 2014 · Stroke
  69. Pediatric Antiphospholipid Syndrome
    Cassyanne L. Aguiar, Arzu Soybilgic, Tadej Avčin, Barry Lee Myones · 2015 · Current Rheumatology Reports
  70. Paradoxical Embolism
    Bradley A. Maron, Prem Shekar, Samuel Zachary Goldhaber · 2010 · Circulation
  71. Evaluation and Management of Transient Ischemic Attack and Minor Cerebral Infarction
    Kelly D. Flemming, Robert D. Brown, George W. Petty, John Huston, David F. Kallmes, David G. Piepgras · 2004 · Mayo Clinic Proceedings
  72. The American Heart Association’s Principles for Comparative Effectiveness Research
    Raymond J. Gibbons, Timothy J. Gardner, Jeffrey L. Anderson, Larry B. Goldstein, Neil M. Meltzer, William S. Weintraub, Clyde W. Yancy · 2009 · Circulation
  73. Hemodynamic Reserve and High-Intensity Transient Signals in Moyamoya Disease
    Péter Horn, Oliver Lanczik, Peter Vajkoczy, Michael Daffertshofer, Eva Bueltmann, Axel Werner, Peter Schmiedek, Michael G. Hennerici · 2005 · Cerebrovascular Diseases
  74. Temporary Endovascular Bypass: A Novel Treatment for Acute Stroke: Fig 1.
    Erik Friedrich Hauck, J Mocco, Kenneth V. Snyder, Elad I. Levy · 2009 · American Journal of Neuroradiology
  75. Acute Therapy and Prevention of Stroke in Spontaneous Carotid Dissection
    Dimitrios Georgiadis, Valeria Caso, Ralf Werner Baumgartner · 2006 · Clinical and Experimental Hypertension
  76. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico
    Blanca Fuentes, J. Gállego, Antonio Gil-Núñez, Ana Morales, Francisco F. Purroy, Jaume Roquer, Tomás Segura, Javier Tejada, Aida Pilar Lago, Exuperio Díez‐Tejedor et al. · 2011 · Neurología
  77. Treatment of Acute Ischemic Stroke
    Joseph P. Broderick, Werner Hacke · 2002 · Circulation
  78. Natural History of Intracranial Atherosclerosis: A Critical Review
    Ricardo J. Komotar, David A. Wilson, J Mocco, Jess E. Jones, Edward Sander Connolly, Sean D. Lavine, Philip M. Meyers · 2006 · Neurosurgery
  79. First-generation agents: aspirin, heparin and coumarins
    Richard L. Mueller · 2004 · Best Practice & Research Clinical Haematology
  80. Adverse Effects and Drug Interactions of Antithrombotic Agents Used in Prevention of Ischaemic Stroke
    Jesse M. Weinberger · 2005 · Drugs
  81. Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome
    Ronald H. W. M. Derksen, Philip G. de Groot, Laurens Jaap Kappelle · 2003 · Neurology
  82. Small Vessel Cerebrovascular Disease: The Past, Present, and Future
    Réza Behrouz, Ali R. Malek, Michel Torbey · 2012 · Stroke Research and Treatment
  83. Cardiac Biomarkers Predict Large Vessel Occlusion in Patients with Ischemic Stroke
    Andrew Chang, Brittany A. Ricci, Brian Mac Grory, Shawna Cutting, Tina M. Burton, Katarina B. Dakay, Mahesh V. Jayaraman, Alexander Eliot Merkler, Michael E. Reznik, Michael P. Lerario et al. · 2019 · Journal of Stroke and Cerebrovascular Diseases
  84. Cryptogenic Stroke: Diagnostic Workup and Management
    Brian Mac Grory, Shane Patrick Flood, Eirini Apostolidou, Shadi R. Yaghi · 2019 · Current Treatment Options in Cardiovascular Medicine
  85. Antithrombotic Agents in the Prevention of Ischemic Stroke
    Marie‐Germaine Bousser · 2009 · Cerebrovascular Diseases
  86. Current and future concepts in stroke prevention
    Fintan O’Rourke · 2004 · Canadian Medical Association Journal
  87. Undetermined stroke with an embolic pattern—a common phenotype with high early recurrence risk
    Jukka Putaala A, Tuomo V. M. Nieminen, Elena Haapaniemi, Atte Meretoja, Kirsi K. Rantanen, Noora Heikkinen, Janne Kinnunen, Daniel Strbian, Satu M. Mustanoja, Sami Curtze et al. · 2015 · Annals of Medicine
  88. Embolic strokes of undetermined source: theoretical construct or useful clinical tool?
    Georgios K. Tsivgoulis, Aristeidis H. Katsanos, Martin Köhrmann, Valeria Caso, Robin Lemmens, Konstantinos P Tsioufis, George P. Paraskevas, Natan M. Bornstein, Peter Dieter Schellinger, Andrei V. Alexandrov et al. · 2019 · Therapeutic Advances in Neurological Disorders
  89. New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention
    Aristeidis H. Katsanos, Robert G. Hart · 2020 · JAMA Neurology
  90. Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke
    Sujoy Kumar Ghosh, Arjun Kumar Ghosh, Arjun Kumar Ghosh · 2007 · Postgraduate Medical Journal
  91. Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events
    Kumar Rajamani, Seemant Chaturvedi, Zhezhen Jin, Shunichi Homma, Robin L. Brey, Barbara C. Tilley, Ralph L. Sacco, John L.P. Thompson, J.P. Mohr, Steven R. Levine · 2009 · Stroke
  92. Evidence based treatment of the antiphospholipid syndrome
    Mark Andrew Crowther, Finn Wislöff · 2004 · Thrombosis Research
  93. Neural Stem Cells Reduce Brain Injury After Unilateral Carotid Ligation
    Anne M. Comi, Eunpi Cho, Justin D. Mulholland, Andrew Hooper, Qun Li, Yun Qu, Devin S. Gary, John W. McDonald, Michael V. Johnston · 2008 · Pediatric Neurology
  94. Cerebrovascular disease in pregnancy
    Michael A. Sloan, Barney J. Stern · 2003 · Current Treatment Options in Neurology
  95. Percutaneous patent foramen ovale and atrial septal defect closure in adults: Results and device comparison in 100 consecutive implants at a single center
    Howard C. Herrmann, Frank E. Silvestry, Ruchira Glaser, Vincent Y. See, Scott Eric Kasner, Danielle Bradbury, Gene Chang, John Winslow Hirshfeld, Phillip A. Horwitz, Michael Kelly · 2005 · Catheterization and Cardiovascular Interventions
  96. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance
    Chetan Varma, Lee N. Benson, Matthew R. Warr, Erik L Yeo, James Yip, Cheryl S. Jaigobin, Gary D. Webb, Peter R. McLaughlin · 2004 · Catheterization and Cardiovascular Interventions
  97. Patent Foramen Ovale, Systemic Embolization, and Closure
    David R. Holmes, Howard A. Cohen, Carlos E. Ruiz · 2009 · Current Problems in Cardiology
  98. Stroke in the elderly.
    Mitchell S.V. Elkind · 2003 · PubMed
  99. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio
    Amory, Colum F., Levine, Steven R., Brey, Robin L., Gebregziabher, Mulugeta, Tuhrim, Stanley, Tilley, Barbara C., Simpson, Ann-Catherin C., Sacco, Ralph L., Mohr, Jay P., for the APASS-WARSS Collaborators · 2015 · Cerebrovascular Diseases
  100. Cryptogenic Stroke, Aortic Arch Atheroma, Patent Foramen Ovale, and the Risk of Stroke
    Pierre Amarenco · 2005 · Cerebrovascular Diseases